| Aug 3 |
Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now
|
| Aug 2 |
Compared to Estimates, Vertex (VRTX) Q2 Earnings: A Look at Key Metrics
|
| Aug 2 |
3 Biotech Stocks That Could Have Investors Grinning Soon
|
| Aug 2 |
Vertex boosts revenue forecast on back of cystic fibrosis franchise growth
|
| Aug 2 |
Vertex (VRTX) Q2 Loss Wider Than Expected, '24 Sales View Raised
|
| Aug 2 |
Vertex Pharma: Driving Growth Through Suzetrigine And Next-Gen Cystic Fibrosis Treatment
|
| Aug 2 |
Vir retreats from infectious disease; Vertex shelves AATD drugs
|
| Aug 2 |
Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.
|
| Aug 2 |
Vertex Stock: Came For CF Drugs, Staying For Gene Therapy
|
| Aug 2 |
Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript
|
